✦ LIBER ✦

Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers

✍ Scribed by Hopkins, Robert J.; Daczkowski, Nancy F.; Kaptur, Paulina E.; Muse, Derek; Sheldon, Eric; LaForce, Craig; Sari, Suha; Rudge, Thomas L.; Bernton, Edward

Book ID: 123193097
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 1013 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2013.04.063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of SC599, an o

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

✍ Odile Launay; Christine Sadorge; Nathalie Jolly; Béatrice Poirier; Stéphane Béch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 795 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants

✍ David I. Bernstein; Judith Falloon; Tingting Yi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 596 KB

A phase I, double-blind, randomized, pla

A phase I, double-blind, randomized, placebo-controlled study to investigate the safety tolerability and pharmacokinetic profile of S-3304, a matrix metalloproteinase inhibitor, when given in multiple doses with high doses for 4 weeks to healthy volunteers

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 277 KB